FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2613363961> ?p ?o ?g. }

• W2613363961 abstract "Background: Hepatitis C Virus (HCV) infection is one of the causes for liver cirrhosis and hepatocellular carcinoma leading to liver failure. An estimated 2-3% of the world population is chronically infected with HCV. HCV is a positive single stranded RNA virus encoding for a single polypeptide, which cleaves into structural and non-structural proteins. The non-structural (NS) proteins play critical roles in viral replication and have become the targets for HCV chemotherapy. The current treatment involves pegylated interferon-α/ribavirin-based treatment and a combination of direct-acting antivirals. NS5B is a critical enzyme for the replication of HCV RNA and is an interesting target for the screening and design of small molecule inhibitors to interfere in the HCV viral replication. Methods: Screening of a library of compounds in a replicon assay, a thiazolone derivative was identified as a NS5B enzyme inhibitor (IC50: 11 µM). Based on the structure of this lead compound, few libraries of compounds were designed and synthesized following a fragment based approach. Structural features of both peptide-based and non-peptide-based protease inhibitors such as lopinavir and tipranavir were considered while designing novel compounds. Results: Several novel protease inhibitors were designed and synthesized based on the structural fragments of lopinavir and tipranavir. This resulted in identification of compounds with thiazolone scaffold as having good anti-HCV NS5B enzyme activity. However, to improve their cellular activity, the thiazolone scaffold was then tethered with several amino acids and then screened for their anti-HCV activity which led to finding a tethered thiazolone as novel hepatitis C NS5B polymerase inhibitor with good cellular potency (EC50 = 1.2 µM). Conclusion: Systematic modification of lead compound (EC50 = 35 µM) from an enzyme assay and by tethering with a suitable amino acid improved the cellular potency of the lead compound. This resulted in a compound 18c with nearly 30 fold (EC50 = 1.2 µM) potent compound in cellular assay than the original lead compound. It's believed that this improvement was possible because of better transport of the active compound into the cell due to its amino acid tether. Keywords: Amino acid, tethered thiazolone, library, hepatitis C, NS5B polymerase inhibitors, liver failure." @default.
• W2613363961 created "2017-05-19" @default.
• W2613363961 creator A5012740216 @default.
• W2613363961 creator A5022031032 @default.
• W2613363961 creator A5076807888 @default.
• W2613363961 date "2017-10-31" @default.
• W2613363961 modified "2023-09-25" @default.
• W2613363961 title "Design and Synthesis of Amino Acid Tethered Thiazolones to Screen for Hepatitis C NS5B Polymerase Inhibitors" @default.
• W2613363961 doi "https://doi.org/10.2174/1570180814666170505121156" @default.
• W2613363961 hasPublicationYear "2017" @default.
• W2613363961 type Work @default.
• W2613363961 sameAs 2613363961 @default.
• W2613363961 citedByCount "0" @default.
• W2613363961 crossrefType "journal-article" @default.
• W2613363961 hasAuthorship W2613363961A5012740216 @default.
• W2613363961 hasAuthorship W2613363961A5022031032 @default.
• W2613363961 hasAuthorship W2613363961A5076807888 @default.
• W2613363961 hasConcept C104317684 @default.
• W2613363961 hasConcept C132379496 @default.
• W2613363961 hasConcept C159047783 @default.
• W2613363961 hasConcept C18103114 @default.
• W2613363961 hasConcept C181199279 @default.
• W2613363961 hasConcept C185592680 @default.
• W2613363961 hasConcept C22744801 @default.
• W2613363961 hasConcept C2522874641 @default.
• W2613363961 hasConcept C2776408679 @default.
• W2613363961 hasConcept C2776714187 @default.
• W2613363961 hasConcept C2781426373 @default.
• W2613363961 hasConcept C2781463415 @default.
• W2613363961 hasConcept C55493867 @default.
• W2613363961 hasConcept C82381507 @default.
• W2613363961 hasConcept C83100098 @default.
• W2613363961 hasConcept C86803240 @default.
• W2613363961 hasConceptScore W2613363961C104317684 @default.
• W2613363961 hasConceptScore W2613363961C132379496 @default.
• W2613363961 hasConceptScore W2613363961C159047783 @default.
• W2613363961 hasConceptScore W2613363961C18103114 @default.
• W2613363961 hasConceptScore W2613363961C181199279 @default.
• W2613363961 hasConceptScore W2613363961C185592680 @default.
• W2613363961 hasConceptScore W2613363961C22744801 @default.
• W2613363961 hasConceptScore W2613363961C2522874641 @default.
• W2613363961 hasConceptScore W2613363961C2776408679 @default.
• W2613363961 hasConceptScore W2613363961C2776714187 @default.
• W2613363961 hasConceptScore W2613363961C2781426373 @default.
• W2613363961 hasConceptScore W2613363961C2781463415 @default.
• W2613363961 hasConceptScore W2613363961C55493867 @default.
• W2613363961 hasConceptScore W2613363961C82381507 @default.
• W2613363961 hasConceptScore W2613363961C83100098 @default.
• W2613363961 hasConceptScore W2613363961C86803240 @default.
• W2613363961 hasIssue "12" @default.
• W2613363961 hasLocation W26133639611 @default.
• W2613363961 hasOpenAccess W2613363961 @default.
• W2613363961 hasPrimaryLocation W26133639611 @default.
• W2613363961 hasRelatedWork W105195041 @default.
• W2613363961 hasRelatedWork W1545947145 @default.
• W2613363961 hasRelatedWork W1994024058 @default.
• W2613363961 hasRelatedWork W2064569884 @default.
• W2613363961 hasRelatedWork W2091710789 @default.
• W2613363961 hasRelatedWork W2096426963 @default.
• W2613363961 hasRelatedWork W2255603241 @default.
• W2613363961 hasRelatedWork W2417175264 @default.
• W2613363961 hasRelatedWork W2793987269 @default.
• W2613363961 hasRelatedWork W652039212 @default.
• W2613363961 hasVolume "14" @default.
• W2613363961 isParatext "false" @default.
• W2613363961 isRetracted "false" @default.
• W2613363961 magId "2613363961" @default.
• W2613363961 workType "article" @default.